
William L. Miller
Examiner (ID: 12563, Phone: (571)272-7068 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3628, 3633, 3677, 3509 |
| Total Applications | 3224 |
| Issued Applications | 2464 |
| Pending Applications | 166 |
| Abandoned Applications | 639 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20262974
[patent_doc_number] => 12433942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/396787
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 94
[patent_figures_cnt] => 98
[patent_no_of_words] => 91591
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18396787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/396787 | Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof | Dec 26, 2023 | Issued |
Array
(
[id] => 19359353
[patent_doc_number] => 20240261387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => RESPIRATORY SYNCYTIAL VIRUS MRNA VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/394486
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394486
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394486 | Respiratory syncytial virus mRNA vaccine | Dec 21, 2023 | Issued |
Array
(
[id] => 19570410
[patent_doc_number] => 20240374702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/542330
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542330
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/542330 | RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF | Dec 14, 2023 | Abandoned |
Array
(
[id] => 19730149
[patent_doc_number] => 12208135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Formulations of dengue virus vaccine compositions
[patent_app_type] => utility
[patent_app_number] => 18/530421
[patent_app_country] => US
[patent_app_date] => 2023-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 19743
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18530421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/530421 | Formulations of dengue virus vaccine compositions | Dec 5, 2023 | Issued |
Array
(
[id] => 19020150
[patent_doc_number] => 20240076321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => PCV2 ORF2 PROTEIN VARIANT AND VIRUS LIKE PARTICLES COMPOSED THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/516237
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516237
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/516237 | PCV2 ORF2 protein variant and virus like particles composed thereof | Nov 20, 2023 | Issued |
Array
(
[id] => 19246871
[patent_doc_number] => 20240197855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => FOOT-AND-MOUTH DISEASE VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/511123
[patent_app_country] => US
[patent_app_date] => 2023-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511123
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/511123 | Foot-and-mouth disease vaccine | Nov 15, 2023 | Issued |
Array
(
[id] => 19667780
[patent_doc_number] => 12180513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells
[patent_app_type] => utility
[patent_app_number] => 18/498879
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3305
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18498879
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/498879 | Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells | Oct 30, 2023 | Issued |
Array
(
[id] => 19762167
[patent_doc_number] => 12220437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Oncolytic virus improved in safety and anticancer effect
[patent_app_type] => utility
[patent_app_number] => 18/492535
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11522
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492535
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/492535 | Oncolytic virus improved in safety and anticancer effect | Oct 22, 2023 | Issued |
Array
(
[id] => 19128535
[patent_doc_number] => 20240133888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => NANOSTRUCTURE FOR DETECTING VIRUSES CONTAINING AMPHIPATHIC POLYMER AND DIAGNOSTIC PLATFORM USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/381221
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/381221 | NANOSTRUCTURE FOR DETECTING VIRUSES CONTAINING AMPHIPATHIC POLYMER AND DIAGNOSTIC PLATFORM USING THE SAME | Oct 17, 2023 | Pending |
Array
(
[id] => 19128535
[patent_doc_number] => 20240133888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => NANOSTRUCTURE FOR DETECTING VIRUSES CONTAINING AMPHIPATHIC POLYMER AND DIAGNOSTIC PLATFORM USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/381221
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/381221 | NANOSTRUCTURE FOR DETECTING VIRUSES CONTAINING AMPHIPATHIC POLYMER AND DIAGNOSTIC PLATFORM USING THE SAME | Oct 16, 2023 | Pending |
Array
(
[id] => 19232222
[patent_doc_number] => 20240189413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/376177
[patent_app_country] => US
[patent_app_date] => 2023-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376177
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376177 | Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines | Oct 2, 2023 | Abandoned |
Array
(
[id] => 19472611
[patent_doc_number] => 12102674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Universal influenza vaccine
[patent_app_type] => utility
[patent_app_number] => 18/477695
[patent_app_country] => US
[patent_app_date] => 2023-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 8200
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18477695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/477695 | Universal influenza vaccine | Sep 28, 2023 | Issued |
Array
(
[id] => 19065718
[patent_doc_number] => 20240100144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => IMMUNOGENIC COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/476042
[patent_app_country] => US
[patent_app_date] => 2023-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18476042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/476042 | Immunogenic compositions and uses thereof | Sep 26, 2023 | Issued |
Array
(
[id] => 20077557
[patent_doc_number] => 12351607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Horn fly vaccine compositions and methods of making same
[patent_app_type] => utility
[patent_app_number] => 18/242627
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2330
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242627 | Horn fly vaccine compositions and methods of making same | Sep 5, 2023 | Issued |
Array
(
[id] => 19050869
[patent_doc_number] => 20240092838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/461369
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461369 | Porcine circovirus type 3 immunogenic compositions and methods of making and using the same | Sep 4, 2023 | Issued |
Array
(
[id] => 18893809
[patent_doc_number] => 20240009294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => HPV Therapeutic Nucleic Acid Vaccine
[patent_app_type] => utility
[patent_app_number] => 18/237913
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18237913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/237913 | HPV therapeutic nucleic acid vaccine | Aug 24, 2023 | Issued |
Array
(
[id] => 18877554
[patent_doc_number] => 20240000923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/366839
[patent_app_country] => US
[patent_app_date] => 2023-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366839
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/366839 | VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE | Aug 7, 2023 | Abandoned |
Array
(
[id] => 18994643
[patent_doc_number] => 11911460
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-27
[patent_title] => Lipid delivery system and virus-like structure (VLS) vaccine constructed therefrom
[patent_app_type] => utility
[patent_app_number] => 18/228700
[patent_app_country] => US
[patent_app_date] => 2023-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 20
[patent_no_of_words] => 4206
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18228700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/228700 | Lipid delivery system and virus-like structure (VLS) vaccine constructed therefrom | Jul 31, 2023 | Issued |
Array
(
[id] => 18771133
[patent_doc_number] => 20230365943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/354172
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354172
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354172 | Adenoviruses and methods for using adenoviruses | Jul 17, 2023 | Issued |
Array
(
[id] => 18923303
[patent_doc_number] => 20240026307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/353375
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353375
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/353375 | Adenoviruses and methods for using adenoviruses | Jul 16, 2023 | Issued |